Association between activated renin angiotensin system and bone formation in hemodialysis patients: Is the bone mass genetically determined by ACE gene polymorphism?

Renal Failure

Volumn 26, Issue 4, 2004, Pages 425-431

  Altun, Bülent ^a   Kiykim, Ahmet Alper ^a   Seyrantepe, Volkan ^a   Usalan, Celalettin ^a   Arici, Mustafa ^a   Çaǧlar, Meltem ^a   Erdem, Yunus ^a   Yasavul, Ünal ^a   Turgan, Çetin ^a   Çaǧla, Şali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme gene polymorphism; Bone; Hemodialysis; Renin angiotensin system

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANGIOTENSIN RECEPTOR; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LUMBAR SPINE; MALE; OSSIFICATION; OSTEOPENIA; PARATHYROID HORMONE BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UROLITHIASIS;

ADULT; BONE DENSITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEOGENESIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENAL DIALYSIS; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 4444276393     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120039830     Document Type: Article

References (28)

1. Canalis, E. The hormonal and local regulation of bone formation. Endocrin. Rev. 1983, 4, 62-77.
2. Hock, J.M.; Centralla, M.; Canalis, E. Insulin like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988, 122, 254-260.
3. Zheng, Z.G.; Wood, D.A.; Sims, S.A.; Dixon, S.J. PAF stumulates resorption by rabbit osteoclasts in vitro. Am. J. Physiol. 1993, 264, E74-E81.
4. Centralla, M.; Mc Carthy, T.; Canalis, E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast enriched cell cultures. J. Biol. Chem. 1987, 262, 2869-2874.
5. Hiruma, Y.; Inoue, A.; Hirose, S. Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvaria. Biochem. Biophys. Res. Commun. 1997, 230, 176-178.
6. Lamparter, S.; Kling, L.; Schrader, M. Effect of angiotensin II on bone cells in vitro. J. Cell. Physiol. 1998, 175, 89-98.
7. Hatton, R.; Stimpel, M.; Chambers, T.J. Angiotensin II generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J. Endocrinol. 1997, 152, 5-10.
8. Pocock, N.A.; Eisman, J.A.; Hooper, J.; Yeates, M.; Sambrock, P.N.; Elberl, S. Genetic determinants of bone mass in adults. J. Clin. Invest. 1987, 80, 706-710.
9. Morrison, N.A.; Qi, J.C.; Tokito, A. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367, 284-287.
10. Kobayashi, S.; Inoue, S.; Hosoi, T.; Ouchi, Y.; Shiraki, M.; Orimo, H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 1996, 11, 306-311.
11. Grant, S.F.A.; Reid, D.M.; Blake, G.; Herd, R.; Fogelman, I.; Ralston, S.H. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collgen type 1 alpha gene. Nat. Genet. 1996, 14, 203-205.
12. Yoshida, H.; Kon, V.; Ichikawa, I. Polymorphims of the renin angiotenin system genes in progressive renal diseases. Kidney Int. 1996, 50, 732-744.
13. Rigat, B.; Hubert, C.; Gelas, F.; Cambien, F.; Corvol, P.; Soubrier, F. An insertion and deletion polymorphism in the angiotensin I converting enzyme gene accounting for half variance in serum enzyme levels. J. Clin. Invest. 1990, 86, 1343-1346.
14. Costerousse, O.; Allegrini, J.; Lopez, M.; Alhanec, G.; Gelas, F. Angiotensin converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem. J. 1993, 290, 33-40.
15. Osono, E.; Kurihara, S.; Hayama, N.; Sakurai, Y.; Ohwada, K.; Onoda, N.; Takeuchi, M.; Tomizawa, T.; Komaba, Y.; Hashimato, K.; Matsunobu, S.; Yoneshima, H.; Lino, Y. Insertion and deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end stage renal failure. Am. J. Kidney Dis. 1998, 32, 725-730.
16. Coen, G.; Ballanti, P.; Bonucci, E.; Calabria, S.; Centorrino, M.; Fassino, V.; Manni, M.; Mantella, D.; Mazzaferro, S.; Napelotano, I.; Sardella, D.; Taggi, F. Bone markers in the diagnosis of low turnover osteodystrophy. Nephrol. Dial. Transplant. 1998, 13, 2294-2302.
17. Gerakis, A.; Hutchison, A.J.; Apostolou, T.H.; Freemont, A.J.; Billis, A. Biochemical markers for non invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on hemodialysis. Nephrol. Dial. Transplant. 1996, 11, 2430-2438.
18. Yoshida, H.; Kuriyama, S.; Atsumi, Y.; Tomonari, H.; Mitaray, T.; Hamaguchi, A.; Kubo, H.; Kawaguchi, Y.; Kon, V.; Matsuokaaa, K.; Ichikawa, I.; Sakai, O. Angiotensin I converting enzyme gene polymorphism in non insulin dependent diabetes mellitus. Kidney Int. 1996, 50, 657-664.
19. National Osteoporosis Foundation. Association between activated renin-angiotensin system and bone formation in hemodialysis patients: is the bone mass genetically determined by ACE gene polymorphism? Osteoporos. Int. 1998, 4 (suppl), S7-S80.
20. Barr, M.J.; Cohen, M.M.J. ACE inhibitor fetopathy and hypocalvaria the kidney-skull connection. Teratology 1991, 44, 485-495.
21. Mehta, N.; Modt, N. ACE inhibitors in pregnancy. Lancet 1989, ii, 96,
22. Tylavsky, F.A.; Johnson, K.C.; Wan, J.Y.; Harshfield, G. Plasma renin activity is associated with bone mineral density in premenopausal women. Osteoporos. Int. 1998, 8, 136-140.
23. Garnero, P.; Sornay Rendue, E.; Delmas, P.D. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenauposal women. J. Bone Miner. Res. 1995, 10, 1283-1288.
24. Salamone, L.M.; Ferrel, R.; Black, D.M. The association between Vitamin D receptor gene polymorphisms and bone mineral density at the spine hip and whole body in premenopausal women. Osteoporos. Int. 1996, 6, 63-68.
25. Cooper, G.S.; Umbach, D.M. Are vitamin D gene polymorphism associated with bone mineral density? A meta analysis. J. Bone Miner. Res. 1996, 11, 1841-1849.
26. Akiba, T.; Ando, R.; Kurihara, S.; Heishi, M.; Tazawa, H.; Marumo, F. Is the bone mass of hemodialysis patients genetically determined? Kidney Inter., Suppl, 1997, 62, 69-72.
27. Alonso, C.G.; Diaz, M.N.; Corte, D.C.; Martin, F.L.; Andia, J.B. Vitamin D receptor gene (VDR) polymorphisms: effect on bone mass, bone loss and paratyroid hormone regulation. Nephrol. Dial. Transplant. 1998, 13, 73-77.
28. Torres, A.; Salido, E. Vitamin D receptor genotype its role in bone mass and turnover in non-renal and renal patients. Nephrol. Dial. Transplant. 1997, 12, 1811-1812.